MedTrace Logo

Sodium Hyaluronate for Myofascial Thoracic Pain

NCT07775274 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-08-20

No results posted yet for this study

Summary

To determine whether the addition of sodium hyaluronate to standard ultrasoundguided lidocaine injection provides superior and sustained pain relief compared with standard lidocaine injection alone in patients with suspected myofascial or nonspecific thoracic back pain.

Conditions

Interventions

OTHER

Sodium Hyaluronate Injection

Sodium hyaluronate injections added to standard lidocaine injection.

OTHER

Saline Injections

Normal saline added to standard lidocaine injection, which reflects current clinical practice.

Sponsors & Collaborators

  • EPC Education s.r.o.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2027-02-20
Completion
2029-02-20

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07775274 on ClinicalTrials.gov